Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome

Erbguth, F; Claus, D; Engelhardt, A; Dressler, D
November 1993
Journal of Neurology, Neurosurgery & Psychiatry;Nov1993, Vol. 56 Issue 11, p1235
Academic Journal
case study
No abstract available.


Related Articles

  • Subclinical Myasthenia Gravis causing increased sensitivity to botulinum toxin therapy. Dressler, Dirk // Journal of Neural Transmission;Nov2010, Vol. 117 Issue 11, p1293 

    In rare patients receiving botulinum toxin (BT) therapy the potency of the BT drug may be increased by pre-existent impairment of neuromuscular transmission (INT). Appropriate dose adjustment may correct for this. Subclinical INT has previously been described by us for the first time in a...

  • Eaton-Lambert syndrome.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p716 

    An encyclopedia entry for "Eaton-Lambert syndrome," which refers to Lambert-Eaton myasthenic syndrome, is presented.

  • Eaton-Lambert syndrome.  // Taber's Cyclopedic Medical Dictionary;2005, p658 

    A definition of the medical term "Eaton-Lambert syndrome" is presented, which means Lambert-Eaton myasthenic syndrome.

  • Pregnancy and delivery of a healthy baby in autoimmune Lambert-Eaton myasthenic syndrome. Schneider-Gold, Christiane; Wessig, Carsten; H�pker, Martin; Erdlenbruch, Bernhard; Gold, Ralf; Toyka, Klaus // Journal of Neurology;Sep2006, Vol. 253 Issue 9, p1236 

    A letter to the editor reporting the Pregnancy and delivery of a healthy baby in autoimmune Lambert-Eaton myasthenic syndrome is presented.

  • Physician, Heal Thyself. Arias, Ron // People;10/15/2001, Vol. 56 Issue 16, p127 

    Profiles Dr. Kevin Parsons and his efforts to fight Lambert-Eaton Myasthenic Syndrome.

  • The potential use of ephedrine in Lambert-Eaton myasthenic syndrome. Cereda, Carlo; Kuntzer, Thierry // Journal of Neurology;Aug2008, Vol. 255 Issue 8, p1259 

    A letter to the editor is presented concerning the possible application of ephedrine in Lambert-Eaton myasthenic syndrome.

  • Neuromuscular Paraneoplastic Syndromes: The Lambert-Eaton Myasthenic Syndrome. Prommer, Eric // Journal of Palliative Medicine;Sep2010, Vol. 13 Issue 9, p1159 

    Background: Disorders in which the effects of cancer occur at a site remote from the primary tumor are termed paraneoplastic disorders. The most well- known paraneoplastic disorder affecting the neuromuscular junction is the Lambert-Eaton myasthenic syndrome (LEMS). Discussion: We describe a...

  • Long-Term Follow-Up in Infantile-Onset Lambert-Eaton Myasthenic Syndrome. Portaro, S.; Parisi, D.; Polizzi, A.; Ruggieri, M.; Andreetta, F.; Bernasconi, P.; Toscano, A.; Rodolico, C. // Journal of Child Neurology;Sep2014, Vol. 29 Issue 9, pNP58 

    Lambert-Eaton myasthenic syndrome is a neuromuscular junction disorder characterized by proximal limb muscle weakness, fatigability, decreased deep-tendon reflexes, and autonomic symptoms. There are 2 forms of Lambert-Eaton myasthenic syndrome: one most frequently associated with small-cell lung...

  • Lambert-Eaton myasthenic syndrome.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1291 

    An encyclopedia entry for "Lambert-Eaton myasthenic syndrome," which refers to an autoimmune syndrome characterized by weakness of the proximal muscles, diminished reflexes and autonomic dysfunction, is presented.

  • Lambert Eaton myasthenic syndrome. Petty, Richard // Practical Neurology (BMJ Publishing Group);Aug2007, Vol. 7 Issue 4, p365 

    The article reports on the Lambert - Eaton myasthenic syndrome. The author describes the medical condition as an autoimmune post-synaptic disorder. The medical condition was discovered in 1956 and was describe as a novel aquired pre-synaptic neuromuscular transmission disorder otherwise known as...


Read the Article


Sign out of this library

Other Topics